RxDoctor Payments Data

Bharath Raj, MD

Psychiatry · Kingwood, TXNPI 1780840587

Payments from drug & device makers

$1,209in general payments, 2019–2025

Across 66 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$355
  • Johnson & Johnson$298
  • Teva Pharmaceuticals USA, Inc.$167
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$72
  • Axsome Therapeutics, Inc.$66
  • Biogen$48
  • plus $204 from 10 others

What the payments were for

  • Food & beverage$1,15896%
  • Education$514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,209 in reported general payments places this provider in the 70th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$50,662
Medicare patients
65
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl197$282,766
VyvanseLisdexamfetamine Dimesylate15$5,701
Lisdexamfetamine Dimesylate20$3,845
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine123$3,239
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine37$1,973
Methylphenidate Hcl30$858
Trazodone Hcl16$543
Duloxetine Hcl25$474
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl12$403
Quetiapine Fumarate27$310
Lamotrigine18$122
Clonazepam31$102
Escitalopram Oxalate30$95
Venlafaxine Hcl ErVenlafaxine Hcl11$84
Mirtazapine16$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$298$282,766197 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Kingwood

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →